Clinical decision support · Research prototype

Models a clinician can argue with.

Decision support that shows you what to change, not just what will happen. Counterfactual clinical AI for high-stakes nephrology, neurovascular, and interventional decisions.

Causal inferencePhysiology-groundedInteractive counterfactuals

01

Working module

09

Dialysis pathways

03

Modules in pipeline

Interactive prototype

Interrogate the intervention.

Constructed patient data for demonstration only. Outputs are simulated projections, not clinical recommendations.

Dialysis counterfactual workspace

Working prototype · In-centre haemodialysis

Live interactive model
Clinical patient cardSynthetic

KUV-HD-0482

64y · Type 2 diabetes · 4.2y on HD

CVC access
Hb 9.8 g/dL
Albumin 3.2 g/dL
hs-CRP ↑

Primary risk signal

Mortality, admission and haemodynamic stability

Counterfactual interventions

Dry weight reduction1.4L
−1.0L−2.0L

Change any assumption. The projected outcomes and mediated pathway update together.

Projected impact

Live model
30-day mortality
10.9%1.9 pp
0Baseline 12.8%
90-day mortality
18.3%3.1 pp
0Baseline 21.4%
1-year mortality
34.3%4.3 pp
0Baseline 38.6%
30-day hospitalisation
27.2%4.0 pp
0Baseline 31.2%

Patient risk trajectory

Baseline mortality, counterfactual mortality and admission risk over time

Controls update all series

Physiological pathway cascade

Mediated effects under the selected counterfactual

Pathway attenuation 20%

Systemic inflammation

Endothelial shear

Myocardial stunning

Cardiac event risk

The premise

“A risk score that cannot be acted on is just anxiety with a number attached.

Traditional predictive ML

Correlation dressed as instruction

The confounding trap

The sickest get the strongest treatment. A model may learn that treatment predicts harm, not that it prevents it.

Feedback loops

Outcomes reflect old practice. When care changes, improvement can look like model failure.

A score identifies risk but leaves the clinical lever hidden.

Kuviyam causal AI

Mechanism made inspectable

01

Read the trajectory

Labs, sessions, medications and events over time—not one convenient snapshot.

02

Route through physiology

Explicit mechanisms with named drivers, thresholds and uncertainty.

03

Test the change

Rank interventions by the risk they may remove for this patient.

Dialysis first · Specialty pipeline

Deep in dialysis. Building carefully beyond it.

Dialysis CoPilot is the active working prototype. Stroke, liver and renal cancer modules remain in the clinical development pipeline.

Working prototype

Renal medicine

Dialysis CoPilot

Surface the modifiable physiology behind mortality and admission risk across a dialysis unit.

  • Vascular access failure
  • Fluid overload mitigation
  • Intradialytic hypotension
Acute stroke brain imaging series
In pipeline

Neurovascular

Stroke Pathway CoPilot

Make time, tissue and haemorrhage trade-offs visible while the treatment window is still open.

  • Penumbra salvage
  • Haemorrhagic transformation
  • Thrombectomy windows

Clinical development pipeline

Liver HCC cross-sectional imaging
In pipeline

Interventional radiology

Liver Intervention CoPilot

Test HCC ablation and embolisation choices against functional liver reserve before treatment.

  • HCC ablation planning
  • Decompensation risk
  • Functional reserve

Clinical development pipeline

Renal cancer imaging for procedure planning
In pipeline

Interventional oncology

Renal Cancer CoPilot

Balance biopsy, ablation margin and nephron protection for small renal masses.

  • T1 renal mass
  • Collecting-system safety
  • Kidney function

Clinical development pipeline

Evidence & governance

Prototype today.
Registry next.
Nothing claimed before it is earned.

The pathway map is a clinical document: reviewable, versioned and open to challenge. Every number shown here comes from constructed test cases—not real patients.

Observational benchmarking

Test against defined cohorts, agreed endpoints and known standards before deployment.

Prospective registry

Track predictions, interventions and outcomes forward—not only against historical records.

IRB-ready governance

Clear data lineage, protocol versioning, access control and institutional review readiness.

Clinician sovereignty

Decision support, never prescription. Uncertainty and missingness remain visible.

Institutional pilot

Bring your hardest cases.
Challenge the model.

We are looking for clinical directors, nephrology and radiology unit heads, and research partners who want assumptions on the table—not buried in a black box.

hello@kuviyam.ai

Submitting opens your email client with these details addressed to us.